Jewel Plummer Cobb was a cancer researcher who investigated how hormones, ultraviolet light and chemotherapeutic drugs can ...

Researchers developed a technique to gain a deeper understanding of ribosome function and their cooperative behaviors.

Tony Oosterveen (left) is a Principal Scientist at bit.bio (Cambridge, UK), a company pioneering the generation of physiologically relevant human cell types from induced pluripotent stem cells (iPSCs) ...

Tia Harmon (left) is a Technical Product Sales Specialist in the cell and gene therapy (CGT) space at PHC Corporation of North America (PHCNA; IL, USA) with a background in cancer research. In this ...

At AACR 2024, we explored the poster hall to pick out the posters that would interest the BioTechniques reader and those we found delivered the most interesting or surprising findings. Get our ...

Susan Kimber (left) is a Professor at the University of Manchester (UK), where for the past 15 years, she and her lab have been working on human pluripotent stem cells for tissue engineering ...

Cellular metabolism is a powerful indicator of cell activation, differentiation, growth, cell death and disease progression. Therefore, metabolite monitoring offers a way for ...

Researchers have identified the genes involved in the sea cucumber’s gory ritual of expelling and regenerating its gut. Will it become the next important animal model for studies into regenerative ...

What is an RNA sequencing library? In all RNA-seq experiments, a library of cDNA fragments attached to adapters must be synthesized in order for sequencing to be successful. How do you prepare an RNA ...

Could a humble, yet deceptively dangerous, snail provide the answer to the opioid crisis? Deep within the ocean live thousands of fierce predators gliding silently though the water armed with jagged ...

Tiger sharks, always thought to be solitary creatures, might be more sociable than we think and even have preferences for other tiger sharks they spend time with. In a 3-year study conducted by the ...

In this interview, Tong Huo discusses the current landscape of CAR-T therapies and the future of CAR-T, including next-generation approaches, gene-editing innovations and applications beyond oncology.